Filing Details

Accession Number:
0001179110-15-010132
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-22 16:24:04
Reporting Period:
2015-06-19
Filing Date:
2015-06-22
Accepted Time:
2015-06-22 16:24:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1235010 Momenta Pharmaceuticals Inc MNTA Biological Products, (No Disgnostic Substances) (2836) 043561634
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1308911 E John Bishop C/O Momenta Pharmaceuticals, Inc.
675 West Kendall Street
Cambridge MA 02142
Senior Vp, Pharmaceutical Scie No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-06-19 2,554 $15.44 101,934 No 4 M Direct
Common Stock Disposition 2015-06-19 2,554 $25.50 99,380 No 4 S Direct
Common Stock Acquisiton 2015-06-19 18,720 $15.44 118,100 No 4 M Direct
Common Stock Disposition 2015-06-19 18,720 $25.50 99,380 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2015-06-19 2,554 $0.00 2,554 $15.44
Common Stock Stock Option (Right to Buy) Disposition 2015-06-19 18,720 $0.00 18,720 $15.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
18,720 2015-02-14 2022-02-14 No 4 M Direct
0 2015-02-14 2022-02-14 No 4 M Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2013.